Tetra Pharm Technologies ApS: Financial statements 2021
CVR: 40738223
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Tetra Pharm Technologies ApS (CVR 40738223) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,208,286 and a net result of DKK 305,591. Equity in the 2021 report amounted to DKK 9,927,365. The solvency ratio was 68.8%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 3,208,286
- Profit/Loss
- DKK 305,591
- Equity
- DKK 9,927,365
- Total Assets
- DKK 14,428,941
- Employees
- 6
Official annual report
Find more companies like Tetra Pharm Technologies ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 3, 2021, Per Mogens Bugge has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Jesper Breum has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Martin Stefan Rose has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Søren Rose has joined the board of directors of Tetra Pharm Technologies ApS.
As of September 3, 2021, Nikolay Tretiyakov has joined the board of directors of Tetra Pharm Technologies ApS.
Tetra Pharm Technologies ApS has published its interim report for the period August 26, 2019 to December 31, 2020.
About Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Rolf Sass Sørensen and Ulrich Wulff Norden Venge. The board consists of Søren Maarssø (chair), Claus Berner Nielsen, Jesper Breum and Rolf Sass Sørensen. The company's owners include RUMP INVEST ApS, Breum Holding EST. 2016 ApS and BrainFrame ApS. The company has 39 employees (2026). In 2025, the company reported a gross profit of DKK -17,669,007 and a net result of DKK -52,589,605 compared with DKK -55,213,708 the year before. Equity in the 2025 report amounted to DKK -25,844,292.